These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25366794)

  • 1. Vasoactive intestinal polypeptide suppresses proliferation of human cord blood-derived hematopoietic progenitor cells by increasing TNF-α and TGF-β production in the liver.
    Wang L; Xiao Q; Wang CH; Li X; Luo SQ; Tang CW
    Genet Mol Res; 2014 Oct; 13(4):9032-43. PubMed ID: 25366794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells.
    Kawakami M; Kimura T; Kishimoto Y; Tatekawa T; Baba Y; Nishizaki T; Matsuzaki N; Taniguchi Y; Yoshihara S; Ikegame K; Shirakata T; Nishida S; Masuda T; Hosen N; Tsuboi A; Oji Y; Oka Y; Ogawa H; Sonoda Y; Sugiyama H; Kawase I; Soma T
    Leukemia; 2004 May; 18(5):912-21. PubMed ID: 14999295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative variation of vasoactive intestinal polypeptide and its receptor in rat liver during development].
    Wang L; Tang CW; Wang CH; Li X
    Sheng Li Xue Bao; 2005 Jun; 57(3):379-83. PubMed ID: 15968436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor.
    Rameshwar P; Gascon P; Oh HS; Denny TN; Zhu G; Ganea D
    Exp Hematol; 2002 Sep; 30(9):1001-9. PubMed ID: 12225791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Initial research for effects of vasoactive intestinal polypeptide (VIP) on differentiation of human umbilical cord blood derived CD34+ cells into hepatic related cells].
    Wang L; Tang CW; Wang CH; Li X; Qiang O; Huang MH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):578-82. PubMed ID: 16909606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
    J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide increases VEGF expression to promote proliferation of brain vascular endothelial cells via the cAMP/PKA pathway after ischemic insult in vitro.
    Yang J; Shi QD; Song TB; Feng GF; Zang WJ; Zong CH; Chang L
    Peptides; 2013 Apr; 42():105-11. PubMed ID: 23340020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver.
    Chastre E; Emami S; Rosselin G; Gespach C
    Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal peptide is an important endocrine regulatory factor of fetal rat testicular steroidogenesis.
    El-Gehani F; Tena-Sempere M; Huhtaniemi I
    Endocrinology; 1998 Apr; 139(4):1474-80. PubMed ID: 9528923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells.
    Hayez N; Harfi I; Lema-Kisoka R; Svoboda M; Corazza F; Sariban E
    J Neuroimmunol; 2004 Apr; 149(1-2):167-81. PubMed ID: 15020077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transduction of specific inhibition of HuT 78 human T cell chemotaxis by type I vasoactive intestinal peptide receptors.
    Xia M; Gaufo GO; Wang Q; Sreedharan SP; Goetzl EJ
    J Immunol; 1996 Aug; 157(3):1132-8. PubMed ID: 8757618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
    Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
    Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of vasoactive intestinal polypeptide and vasoactive intestinal polypeptide receptor 1 in small intestine and liver during macaque development].
    Guo MM; Huang MH; Wang CH; Tang CW
    Sheng Li Xue Bao; 2007 Apr; 59(2):163-8. PubMed ID: 17437038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vasoactive intestinal peptide on gastric adenocarcinoma.
    Li GH; Qian W; Song GQ; Hou XH
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1328-35. PubMed ID: 17559364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.